KISNER DANIEL L reported 2 transactions at ZYNERBA PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/11/2023ACC: 0001140361-23-047722
Director
Since Jun 2019
-182.18K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
182.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−27.95K
Price / share
—
Trade value
—
% of position
36.9%
10/10/2023
75.78K→47.82K
Common Stock
Direct
Shares
−47.82K
Price / share
—
Trade value
—
% of position
New position
10/10/2023
47.82K→0.00
Total
Net shares
−75.78K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/10/2023 | U · U | −27.95K | — | — | 36.9% | 75.78K | 47.82K |
| Common Stock Direct | 10/10/2023 | U · U | −47.82K | — | — | New position | 47.82K | 0.00 |
| Total | −75.78K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
34.66K shares
Shares
−34.66K
Strike price
1.01
Held after
0.00
Exercisable
—
10/10/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
71.74K shares
Shares
−71.74K
Strike price
0.3501
Held after
0.00
Exercisable
—
10/10/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock34.66K shares | 10/10/2023 | D · Disposition | −34.66K | 1.01 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock71.74K shares | 10/10/2023 | D · Disposition | −71.74K | 0.3501 | — | 0.00 |